Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JuvaSonic was a medical technology company that developed ultrasound-based platforms for transdermal drug delivery and aesthetic treatments. The company's core technology utilized low-frequency ultrasound to temporarily increase skin permeability, enabling the non-invasive administration of therapeutic agents, including large-molecule biologics and localized pain medications. Based in Ithaca, New York, JuvaSonic aimed to provide needle-free alternatives for drug delivery while also addressing the aesthetic market for skin rejuvenation. The company was founded by Dr. George K. Lewis Jr., a pioneer in miniaturized ultrasound technology, and its intellectual property was closely linked to the development of wearable therapeutic ultrasound devices. JuvaSonic's approach combined ultrasonic engineering with dermatological science to improve patient outcomes in pain management and skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juvasonic.